Innovation Digest – November 2019 Vol. 2

Daily media coverage implies that pricing is the biggest threat to our health and our healthcare system. To be sure, the price of care has been overinflated in every sector, with little correlation to actual patient outcomes and seemingly little consequence for those in power (i.e. not the patient). And, while we’ve invested heavily in identifying and researching patient outcomes that matter, they haven’t yet translated into care that is customized, consistent, universally available and affordable. If patients are the source of important information and are valued as a central actor in their care, we need to invest more in supporting research and shared-data platforms that can help us ask and answer questions that are important to patients.

The CDC’s recent report and my attendance at yet another forum of learned stakeholders discussing the threat of antimicrobial resistance and the barriers that exist to innovation raises a starker question: while we’re obsessed with trying to control the price of services, are we in danger of ignoring real public health threats that will cripple our delivery system and our well-being? As I heard at the recent gathering, the antidote lies in shared responsibility for research, and for smoothing the pathways that allow shared data, diagnostics, therapeutic research and practice implementation to improve our arsenal and our preparedness for the ever-shifting microbes in our midst. It’s past time for the silos of proprietary data/methods/models/algorithms to come down. If we share and collaborate to produce the solution(s), doesn’t everyone win?

In this issue:

  • Biggest Threats and Data
  • The ‘post-antibiotic era’ is here: Drug-resistant superbugs sicken 2.8M and kill 35K each year
  • Important Steps to Advance the Use of Patient-Generated Data
  • Incorporating Patient Perspectives and Transparency for Patient-Centered Value Assessment
  • The Power of Person-Generated Health Data: Five Ways to Improve the Care Experience
  • JAMA: Lower cost hospitals have similar patient outcomes as higher cost counterparts
Back to Viewpoint